Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 335

Results For "CE"

9359 News Found

ScienceMedia and Apex Mobile Clinical Research sign partnership for clinical trial training
Biotech | March 27, 2022

ScienceMedia and Apex Mobile Clinical Research sign partnership for clinical trial training

The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment


RCSE partner with Rela Hospitals for  advanced surgical course
Hospitals | March 26, 2022

RCSE partner with Rela Hospitals for advanced surgical course

These courses are for pre-selected candidates who have completed their MBBS with an additional 2 years of surgical experience training


Medtronic announces first patient implants for bladder incontinence
Medical Device | March 25, 2022

Medtronic announces first patient implants for bladder incontinence

Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy


Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting
News | March 25, 2022

Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting

Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment


Japan approves BMS’ Breyanzi application for relapsed large B-cell lymphoma
Drug Approval | March 25, 2022

Japan approves BMS’ Breyanzi application for relapsed large B-cell lymphoma

This is the first CAR T cell therapy application filed for the second-line treatment of R/R LBCL in Japan


Parata Systems earns HITRUST certification
News | March 25, 2022

Parata Systems earns HITRUST certification

It recognizes the company's commitment to safeguarding sensitive data, protecting patient information


CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma
News | March 25, 2022

CHMP recommends EU approval of Roche’s new combination treatment for large B-cell lymphoma

Recommendation is based on pivotal data from the phase III POLARIX study


LifeMine Therapeutics and GSK enter drug discovery and development alliance
Biotech | March 24, 2022

LifeMine Therapeutics and GSK enter drug discovery and development alliance

The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules


Insilico Medicine and EQRx to jointly advance AI-driven drug discovery
Biotech | March 24, 2022

Insilico Medicine and EQRx to jointly advance AI-driven drug discovery

The collaboration leverages Insilico's end-to-end AI-driven Pharma.AI platform to discover novel small molecule drug candidates for multiple targets, along with EQRx's innovative business model to accelerate drug development and patient access to novel medicines at affordable prices


Lupin receives approval from USFDA for Sildenafil for Oral Suspension
Drug Approval | March 24, 2022

Lupin receives approval from USFDA for Sildenafil for Oral Suspension

The product will be manufactured at Lupin’s facility in Goa, India